Risk of acute renal failure associated with combined use of SGLT2 inhibitors and potentially nephrotoxic drugs: an epidemiological surveillance study based on the FDA adverse event reporting system (FAERS)EXPERT OPINION ON DRUG SAFETYIF3.12025-02-220PRE
Smart Pharmaceutical Monitoring System With Personalized Medication Schedules and Self-Management Programs for Patients With Diabetes: Development and Evaluation StudyJOURNAL OF MEDICAL INTERNET RESEARCHIF62025-02-110OA
Letter: Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 Randomized Controlled COURAGE TrialJOURNAL OF UROLOGYIF6.82024-12-010PRE
Analysis of hemorrhagic drug-drug interactions between P-gp inhibitors and direct oral anticoagulants from the FDA Adverse Event Reporting SystemEXPERT OPINION ON DRUG SAFETYIF3.12024-07-081PRE
Altered hippocampal functional connectivity after the rupture of anterior communicating artery aneurysm前交通动脉瘤破裂后海马功能连接的改变FRONTIERS IN AGING NEUROSCIENCEIF4.52022-11-073OAAI
Altered functional connectivity within default mode network after rupture of anterior communicating artery aneurysmFRONTIERS IN AGING NEUROSCIENCEIF4.52022-07-254OAAI